Thus, overexpression of SRPK1 and/or activation of Akt1/2, combined with their potential nuclear translocation due to cancer-related signaling events [30,39,40,105], may account for changes in LBR binding states and oligomerization forms, resulting in chromatin rearrangement and altered gene expression (for a provisional model see Figure 3). This evidence concerns the gene SRPK1 and cancer.